Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 4053 entries
Sorted by: Best Match Show Resources per page
Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.

PloS one

Gu X, Gao XS, Qin S, Li X, Qi X, Ma M, Yu H, Sun S, Zhou D, Wang W, Xiong W.
PMID: 27658306
PLoS One. 2016 Sep 22;11(9):e0163523. doi: 10.1371/journal.pone.0163523. eCollection 2016.

Platelet to lymphocyte ratio (PLR) is a parameter reflecting inflammatory responses in patients with cancer. Several studies have investigated the prognostic value of PLR in patients with colorectal cancer (CRC); however, the results are controversial. Thus, we carried out...

Cite
Gu X, Gao XS, Qin S, et al. Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer. PLoS One. 2016;11(9):e0163523doi: 10.1371/journal.pone.0163523.
Gu, X., Gao, X. S., Qin, S., Li, X., Qi, X., Ma, M., Yu, H., Sun, S., Zhou, D., Wang, W., & Xiong, W. (2016). Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer. PloS one, 11(9), e0163523. https://doi.org/10.1371/journal.pone.0163523
Gu, Xiaobin, et al. "Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer." PloS one vol. 11,9 (2016): e0163523. doi: https://doi.org/10.1371/journal.pone.0163523
Gu X, Gao XS, Qin S, Li X, Qi X, Ma M, Yu H, Sun S, Zhou D, Wang W, Xiong W. Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer. PLoS One. 2016 Sep 22;11(9):e0163523. doi: 10.1371/journal.pone.0163523. eCollection 2016. PMID: 27658306; PMCID: PMC5033452.
Copy Download .nbib Format: NLM
Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts.

Oncotarget

Wang H, Luo C, Zhu S, Fang H, Gao Q, Ge S, Qu H, Ma Q, Ren H, Wang Y, Wang W.
PMID: 28938643
Oncotarget. 2017 Jul 26;8(35):59376-59386. doi: 10.18632/oncotarget.19587. eCollection 2017 Aug 29.

Colorectal cancer (CRC) is one of the most common malignant neoplasms worldwide. Except for the existing fecal occult blood test, colonoscopy and sigmoidoscopy, no widely accepted

Cite
Wang H, Luo C, Zhu S, et al. Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts. Oncotarget. 2017;8(35):59376-59386doi: 10.18632/oncotarget.19587.
Wang, H., Luo, C., Zhu, S., Fang, H., Gao, Q., Ge, S., Qu, H., Ma, Q., Ren, H., Wang, Y., & Wang, W. (2017). Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts. Oncotarget, 8(35), 59376-59386. https://doi.org/10.18632/oncotarget.19587
Wang, Hao, et al. "Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts." Oncotarget vol. 8,35 (2017): 59376-59386. doi: https://doi.org/10.18632/oncotarget.19587
Wang H, Luo C, Zhu S, Fang H, Gao Q, Ge S, Qu H, Ma Q, Ren H, Wang Y, Wang W. Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts. Oncotarget. 2017 Jul 26;8(35):59376-59386. doi: 10.18632/oncotarget.19587. eCollection 2017 Aug 29. PMID: 28938643; PMCID: PMC5601739.
Copy Download .nbib Format: NLM
LncRNA-Six1 Encodes a Micropeptide to Activate .

Frontiers in physiology

Cai B, Li Z, Ma M, Wang Z, Han P, Abdalla BA, Nie Q, Zhang X.
PMID: 28473774
Front Physiol. 2017 Apr 20;8:230. doi: 10.3389/fphys.2017.00230. eCollection 2017.

Long non-coding RNAs (lncRNAs) play important roles in epigenetic regulation of skeletal muscle development. In our previous RNA-seq study (accession number GSE58755), we found that lncRNA-Six1 is an lncRNA that is differentially expressed between White Recessive Rock (WRR) and...

Cite
Cai B, Li Z, Ma M, et al. LncRNA-Six1 Encodes a Micropeptide to Activate . Front Physiol. 2017;8:230doi: 10.3389/fphys.2017.00230.
Cai, B., Li, Z., Ma, M., Wang, Z., Han, P., Abdalla, B. A., Nie, Q., & Zhang, X. (2017). LncRNA-Six1 Encodes a Micropeptide to Activate . Frontiers in physiology, 8230. https://doi.org/10.3389/fphys.2017.00230
Cai, Bolin, et al. "LncRNA-Six1 Encodes a Micropeptide to Activate ." Frontiers in physiology vol. 8 (2017): 230. doi: https://doi.org/10.3389/fphys.2017.00230
Cai B, Li Z, Ma M, Wang Z, Han P, Abdalla BA, Nie Q, Zhang X. LncRNA-Six1 Encodes a Micropeptide to Activate . Front Physiol. 2017 Apr 20;8:230. doi: 10.3389/fphys.2017.00230. eCollection 2017. PMID: 28473774; PMCID: PMC5397475.
Copy Download .nbib Format: NLM
The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b.

OncoTargets and therapy

Ma Q, Chen Z, Jia G, Lu X, Xie X, Jin W.
PMID: 26309412
Onco Targets Ther. 2015 Aug 10;8:1979-88. doi: 10.2147/OTT.S85443. eCollection 2015.

AIMS: Prostate cancer (PCa) is the most frequently diagnosed malignancy in men. However, the underlying mechanism is not fully understood. In this study, we aim to research the molecular mechanisms underlying the initiation and progression of PCa.RESULTS: Plant homeodomain...

Cite
Ma Q, Chen Z, Jia G, et al. The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b. Onco Targets Ther. 2015;8:1979-88doi: 10.2147/OTT.S85443.
Ma, Q., Chen, Z., Jia, G., Lu, X., Xie, X., & Jin, W. (2015). The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b. OncoTargets and therapy, 81979-88. https://doi.org/10.2147/OTT.S85443
Ma, Qiang, et al. "The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b." OncoTargets and therapy vol. 8 (2015): 1979-88. doi: https://doi.org/10.2147/OTT.S85443
Ma Q, Chen Z, Jia G, Lu X, Xie X, Jin W. The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b. Onco Targets Ther. 2015 Aug 10;8:1979-88. doi: 10.2147/OTT.S85443. eCollection 2015. PMID: 26309412; PMCID: PMC4539089.
Copy Download .nbib Format: NLM
Relaxation matrix for symmetric tops with inversion symmetry: Line coupling and line mixing effects on NH.

The Journal of chemical physics

Ma Q, Boulet C, Tipping RH.
PMID: 28390348
J Chem Phys. 2017 Apr 07;146(13):134312. doi: 10.1063/1.4979492.

Line shape parameters including the half-widths and the off-diagonal elements of the relaxation matrix have been calculated for self-broadened NH

Cite
Ma Q, Boulet C, Tipping RH. Relaxation matrix for symmetric tops with inversion symmetry: Line coupling and line mixing effects on NH. J Chem Phys. 2017;146(13):134312doi: 10.1063/1.4979492.
Ma, Q., Boulet, C., & Tipping, R. H. (2017). Relaxation matrix for symmetric tops with inversion symmetry: Line coupling and line mixing effects on NH. The Journal of chemical physics, 146(13), 134312. https://doi.org/10.1063/1.4979492
Ma, Q, et al. "Relaxation matrix for symmetric tops with inversion symmetry: Line coupling and line mixing effects on NH." The Journal of chemical physics vol. 146,13 (2017): 134312. doi: https://doi.org/10.1063/1.4979492
Ma Q, Boulet C, Tipping RH. Relaxation matrix for symmetric tops with inversion symmetry: Line coupling and line mixing effects on NH. J Chem Phys. 2017 Apr 07;146(13):134312. doi: 10.1063/1.4979492. PMID: 28390348.
Copy Download .nbib Format: NLM
SOS1, HKT1;5, and NHX1 Synergistically Modulate Na.

Frontiers in plant science

Zhang WD, Wang P, Bao Z, Ma Q, Duan LJ, Bao AK, Zhang JL, Wang SM.
PMID: 28450879
Front Plant Sci. 2017 Apr 13;8:576. doi: 10.3389/fpls.2017.00576. eCollection 2017.

No abstract available.

Cite
Zhang WD, Wang P, Bao Z, et al. SOS1, HKT1;5, and NHX1 Synergistically Modulate Na. Front Plant Sci. 2017;8:576doi: 10.3389/fpls.2017.00576.
Zhang, W. D., Wang, P., Bao, Z., Ma, Q., Duan, L. J., Bao, A. K., Zhang, J. L., & Wang, S. M. (2017). SOS1, HKT1;5, and NHX1 Synergistically Modulate Na. Frontiers in plant science, 8576. https://doi.org/10.3389/fpls.2017.00576
Zhang, Wei-Dan, et al. "SOS1, HKT1;5, and NHX1 Synergistically Modulate Na." Frontiers in plant science vol. 8 (2017): 576. doi: https://doi.org/10.3389/fpls.2017.00576
Zhang WD, Wang P, Bao Z, Ma Q, Duan LJ, Bao AK, Zhang JL, Wang SM. SOS1, HKT1;5, and NHX1 Synergistically Modulate Na. Front Plant Sci. 2017 Apr 13;8:576. doi: 10.3389/fpls.2017.00576. eCollection 2017. PMID: 28450879; PMCID: PMC5390037.
Copy Download .nbib Format: NLM
Replicative efficiency and pathogenicity of hepatitis B virus e-minus precore variant.

Journal of gastroenterology and hepatology

Wen YM, Ma ZM, Tu G, Zhai WR, He LF, Yao X.
PMID: 28976680
J Gastroenterol Hepatol. 1998 Nov;13:S304-S307. doi: 10.1111/j.1440-1746.1998.tb01898.x.

To study the replicative efficiency and pathogenicity of hepatitis B virus precore variant (A1896), anti-hepatitis B virus e antigen (HBe) titre was studied in naturally occurring wild-type virus infection, A1896 variant infection and dual infection. Higher titre of anti-HBe...

Cite
Wen YM, Ma ZM, Tu G, et al. Replicative efficiency and pathogenicity of hepatitis B virus e-minus precore variant. J Gastroenterol Hepatol. 1998;13:S304-S307doi: 10.1111/j.1440-1746.1998.tb01898.x.
Wen, Y. M., Ma, Z. M., Tu, G., Zhai, W. R., He, L. F., & Yao, X. (1998). Replicative efficiency and pathogenicity of hepatitis B virus e-minus precore variant. Journal of gastroenterology and hepatology, 13S304-S307. https://doi.org/10.1111/j.1440-1746.1998.tb01898.x
Wen, Yu-Mei, et al. "Replicative efficiency and pathogenicity of hepatitis B virus e-minus precore variant." Journal of gastroenterology and hepatology vol. 13 (1998): S304-S307. doi: https://doi.org/10.1111/j.1440-1746.1998.tb01898.x
Wen YM, Ma ZM, Tu G, Zhai WR, He LF, Yao X. Replicative efficiency and pathogenicity of hepatitis B virus e-minus precore variant. J Gastroenterol Hepatol. 1998 Nov;13:S304-S307. doi: 10.1111/j.1440-1746.1998.tb01898.x. PMID: 28976680.
Copy Download .nbib Format: NLM
FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.

American journal of translational research

Wang J, Liu Z, Zhang D, Liu R, Lin Q, Liu J, Yang Z, Ma Q, Sun D, Zhou X, Jiang G.
PMID: 28861158
Am J Transl Res. 2017 Aug 15;9(8):3676-3686. eCollection 2017.

Failure of cancer treatment caused by drug resistance and metastasis is mainly due to existence of cancer stem cells (CSCs). Therefore, targeting CSCs to overcome cancers is a challenging issue in clinic. In this report, in view of the...

Cite
Wang J, Liu Z, Zhang D, et al. FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties. Am J Transl Res. 2017;9(8):3676-3686
Wang, J., Liu, Z., Zhang, D., Liu, R., Lin, Q., Liu, J., Yang, Z., Ma, Q., Sun, D., Zhou, X., & Jiang, G. (2017). FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties. American journal of translational research, 9(8), 3676-3686.
Wang, Jin, et al. "FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties." American journal of translational research vol. 9,8 (2017): 3676-3686.
Wang J, Liu Z, Zhang D, Liu R, Lin Q, Liu J, Yang Z, Ma Q, Sun D, Zhou X, Jiang G. FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties. Am J Transl Res. 2017 Aug 15;9(8):3676-3686. eCollection 2017. PMID: 28861158; PMCID: PMC5575181.
Copy Download .nbib Format: NLM
Co-, N-, and S-Tridoped Carbon Derived from Nitrogen- and Sulfur-Enriched Polymer and Cobalt Salt for Hydrogen Evolution Reaction.

ACS applied materials & interfaces

Deng W, Jiang H, Chen C, Yang L, Zhang Y, Peng S, Wang S, Tan Y, Ma M, Xie Q.
PMID: 27172131
ACS Appl Mater Interfaces. 2016 Jun 01;8(21):13341-7. doi: 10.1021/acsami.5b12666. Epub 2016 May 19.

A series of cobalt and heteroatom (N and/or S) doped carbon materials were prepared and explored as electrocatalysts for hydrogen evolution reaction (HER). The most active catalyst is a Co-, N-, and S-tridoped carbon (CoNS-C), which was prepared through...

Cite
Deng W, Jiang H, Chen C, et al. Co-, N-, and S-Tridoped Carbon Derived from Nitrogen- and Sulfur-Enriched Polymer and Cobalt Salt for Hydrogen Evolution Reaction. ACS Appl Mater Interfaces. 2016;8(21):13341-7doi: 10.1021/acsami.5b12666.
Deng, W., Jiang, H., Chen, C., Yang, L., Zhang, Y., Peng, S., Wang, S., Tan, Y., Ma, M., & Xie, Q. (2016). Co-, N-, and S-Tridoped Carbon Derived from Nitrogen- and Sulfur-Enriched Polymer and Cobalt Salt for Hydrogen Evolution Reaction. ACS applied materials & interfaces, 8(21), 13341-7. https://doi.org/10.1021/acsami.5b12666
Deng, Wenfang, et al. "Co-, N-, and S-Tridoped Carbon Derived from Nitrogen- and Sulfur-Enriched Polymer and Cobalt Salt for Hydrogen Evolution Reaction." ACS applied materials & interfaces vol. 8,21 (2016): 13341-7. doi: https://doi.org/10.1021/acsami.5b12666
Deng W, Jiang H, Chen C, Yang L, Zhang Y, Peng S, Wang S, Tan Y, Ma M, Xie Q. Co-, N-, and S-Tridoped Carbon Derived from Nitrogen- and Sulfur-Enriched Polymer and Cobalt Salt for Hydrogen Evolution Reaction. ACS Appl Mater Interfaces. 2016 Jun 01;8(21):13341-7. doi: 10.1021/acsami.5b12666. Epub 2016 May 19. PMID: 27172131.
Copy Download .nbib Format: NLM
The impact of anesthesia providers on major morbidity following screening colonoscopies.

Journal of multidisciplinary healthcare

Lubarsky DA, Guercio JR, Hanna JW, Abreu MT, Ma Q, Uribe C, Birnbach DJ, Sinclair DR, Candiotti KA.
PMID: 26060404
J Multidiscip Healthc. 2015 May 28;8:255-70. doi: 10.2147/JMDH.S77408. eCollection 2015.

BACKGROUND AND AIMS: Few studies evaluate the impact of anesthesia providers during procedures, such as colonoscopy, on low-risk patients. The objective of this study was to compare the effect of anesthesia providers on several outcome variables, including major morbidity,...

Cite
Lubarsky DA, Guercio JR, Hanna JW, et al. The impact of anesthesia providers on major morbidity following screening colonoscopies. J Multidiscip Healthc. 2015;8:255-70doi: 10.2147/JMDH.S77408.
Lubarsky, D. A., Guercio, J. R., Hanna, J. W., Abreu, M. T., Ma, Q., Uribe, C., Birnbach, D. J., Sinclair, D. R., & Candiotti, K. A. (2015). The impact of anesthesia providers on major morbidity following screening colonoscopies. Journal of multidisciplinary healthcare, 8255-70. https://doi.org/10.2147/JMDH.S77408
Lubarsky, David A, et al. "The impact of anesthesia providers on major morbidity following screening colonoscopies." Journal of multidisciplinary healthcare vol. 8 (2015): 255-70. doi: https://doi.org/10.2147/JMDH.S77408
Lubarsky DA, Guercio JR, Hanna JW, Abreu MT, Ma Q, Uribe C, Birnbach DJ, Sinclair DR, Candiotti KA. The impact of anesthesia providers on major morbidity following screening colonoscopies. J Multidiscip Healthc. 2015 May 28;8:255-70. doi: 10.2147/JMDH.S77408. eCollection 2015. PMID: 26060404; PMCID: PMC4454218.
Copy Download .nbib Format: NLM
Induction of apoptosis by FFJ-5, a novel naphthoquinone compound, occurs via downregulation of PKM2 in A549 and HepG2 cells.

Oncology letters

Wei X, Li M, Ma M, Jia H, Zhang Y, Kang W, Wang T, Shi X.
PMID: 28356960
Oncol Lett. 2017 Feb;13(2):791-799. doi: 10.3892/ol.2016.5522. Epub 2016 Dec 20.

Pyruvate kinase isoenzyme M2 (PKM2) has previously been identified as a tumor biomarker and as a potential target for cancer therapy. In this study, F§FJ-5, a characterized naphthoquinone modifier of mollugin, was synthesized in order to investigate its anticancer...

Cite
Wei X, Li M, Ma M, et al. Induction of apoptosis by FFJ-5, a novel naphthoquinone compound, occurs via downregulation of PKM2 in A549 and HepG2 cells. Oncol Lett. 2016;13(2):791-799doi: 10.3892/ol.2016.5522.
Wei, X., Li, M., Ma, M., Jia, H., Zhang, Y., Kang, W., Wang, T., & Shi, X. (2017). Induction of apoptosis by FFJ-5, a novel naphthoquinone compound, occurs via downregulation of PKM2 in A549 and HepG2 cells. Oncology letters, 13(2), 791-799. https://doi.org/10.3892/ol.2016.5522
Wei, Xiaoli, et al. "Induction of apoptosis by FFJ-5, a novel naphthoquinone compound, occurs via downregulation of PKM2 in A549 and HepG2 cells." Oncology letters vol. 13,2 (2017): 791-799. doi: https://doi.org/10.3892/ol.2016.5522
Wei X, Li M, Ma M, Jia H, Zhang Y, Kang W, Wang T, Shi X. Induction of apoptosis by FFJ-5, a novel naphthoquinone compound, occurs via downregulation of PKM2 in A549 and HepG2 cells. Oncol Lett. 2017 Feb;13(2):791-799. doi: 10.3892/ol.2016.5522. Epub 2016 Dec 20. PMID: 28356960; PMCID: PMC5351257.
Copy Download .nbib Format: NLM
For non-small cell lung cancer with T3 (central) disease, sleeve lobectomy or pneumonectomy?.

Journal of thoracic disease

Ma QL, Guo YQ, Shi B, Tian YC, Song ZY, Liu DR.
PMID: 27293841
J Thorac Dis. 2016 Jun;8(6):1227-33. doi: 10.21037/jtd.2016.04.60.

BACKGROUND: Pneumonectomy (PN) has traditionally been the treatment of choice for central lung tumors for which the alternative is sleeve lobectomy (SL). The aim of this study was to compare early and long-term results after SL and PN in...

Cite
Ma QL, Guo YQ, Shi B, et al. For non-small cell lung cancer with T3 (central) disease, sleeve lobectomy or pneumonectomy?. J Thorac Dis. 2016;8(6):1227-33doi: 10.21037/jtd.2016.04.60.
Ma, Q. L., Guo, Y. Q., Shi, B., Tian, Y. C., Song, Z. Y., & Liu, D. R. (2016). For non-small cell lung cancer with T3 (central) disease, sleeve lobectomy or pneumonectomy?. Journal of thoracic disease, 8(6), 1227-33. https://doi.org/10.21037/jtd.2016.04.60
Ma, Qian-Li, et al. "For non-small cell lung cancer with T3 (central) disease, sleeve lobectomy or pneumonectomy?." Journal of thoracic disease vol. 8,6 (2016): 1227-33. doi: https://doi.org/10.21037/jtd.2016.04.60
Ma QL, Guo YQ, Shi B, Tian YC, Song ZY, Liu DR. For non-small cell lung cancer with T3 (central) disease, sleeve lobectomy or pneumonectomy?. J Thorac Dis. 2016 Jun;8(6):1227-33. doi: 10.21037/jtd.2016.04.60. PMID: 27293841; PMCID: PMC4886029.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 4053 entries